We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
CALL
Wells Fargo
WFC
$261B
| $22.8M | 0.05% |
552,500
+222,000
| +67% | +$9.83M |
|
|
APLS
402
DELISTED
Apellis Pharmaceuticals
APLS
| $22.6M | 0.05% |
436,423
+99,696
| +30% | +$5.29M |
|
403
Lear
LEA
$7.19B
| $22.5M | 0.05% |
181,418
+64,670
| +55% | +$8.57M |
|
404
CALL
Alibaba
BABA
$269B
| $22.5M | 0.05% |
255,400
-177,100
| -41% | -$14M |
|
405
Campbell Soup
CPB
$6.51B
| $22.4M | 0.05% |
394,803
+86,398
| +28% | +$4.53M |
|
406
iQIYI
IQ
$1.18B
| $22.3M | 0.05% |
4,207,714
+3,632,286
| +631% | +$10.6M |
|
407
Wolfspeed
WOLF
$1.2B
| $22.2M | 0.05% |
322,263
-64,461
| -17% | -$5.71M |
|
|
CHS
408
DELISTED
Chicos FAS, Inc.
CHS
| $22.2M | 0.05% |
4,510,084
-1,228,724
| -21% | -$6.91M |
|
|
ETRN
409
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $22.1M | 0.05% |
+3,291,985
| New | +$25.5M |
|
410
PUT
VanEck Semiconductor ETF
SMH
$67.6B
| $22M | 0.05% |
216,600
-237,600
| -52% | -$24.2M |
|
411
Axalta
AXTA
$7.01B
| $21.9M | 0.05% |
859,791
-1,351,989
| -61% | -$33.4M |
|
|
DAY
412
DELISTED
Dayforce
DAY
| $21.9M | 0.05% |
341,135
-40,667
| -11% | -$2.56M |
|
|
HIBB
413
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $21.9M | 0.05% |
320,580
-128,357
| -29% | -$8M |
|
|
LHCG
414
DELISTED
LHC Group LLC
LHCG
| $21.8M | 0.05% |
134,842
+58,387
| +76% | +$9.64M |
|
415
Global E Online
GLBE
$6.08B
| $21.8M | 0.05% |
1,056,178
-407,321
| -28% | -$9.24M |
|
416
Pinnacle West Capital
PNW
$12.9B
| $21.7M | 0.05% |
285,907
+154,417
| +117% | +$11M |
|
417
PUT
Salesforce
CRM
$134B
| $21.7M | 0.05% |
163,300
+7,100
| +5% | +$1.04M |
|
418
Starwood Property Trust
STWD
$6.12B
| $21.5M | 0.05% |
1,172,363
-410,344
| -26% | -$8.17M |
|
|
VAQC
419
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
| $21.4M | 0.05% |
2,122,701
| – | – |
|
420
Incyte
INCY
$23.5B
| $21.4M | 0.05% |
266,812
+219,012
| +458% | +$16.8M |
|
421
Ball Corp
BALL
$17B
| $21.3M | 0.05% |
416,737
+243,210
| +140% | +$12.6M |
|
422
GE Aerospace
GE
$367B
| $21.3M | 0.05% |
407,925
+381,451
| +1,441% | +$18.8M |
|
|
NAAC
423
DELISTED
North Atlantic Acquisition Corporation Class A Ordinary Share
NAAC
| $21.3M | 0.05% |
2,106,129
| – | – |
|
424
Five Below
FIVE
$11.2B
| $21.3M | 0.05% |
+120,239
| New | +$18.9M |
|
425
PUT
Adobe
ADBE
$89.5B
| $21.2M | 0.05% |
63,000
+14,100
| +29% | +$4.51M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.